Document is current
Any future updates will be listed below
-
Authors
Alkan, H. Furkan
Vesely, Paul W.
Hackl, Hubert
Foßelteder, Johannes
Schmidt, Daniel R.
Vander Heiden, Matthew G.
Pichler, Martin
Hoefler, Gerald
Bogner-Strauss, Juliane G. https://orcid.org/0000-0002-2998-8898
-
Funding
Funding for this research was provided by:
Austrian Science Fund (W1226 DK “Metabolic and Cardiovascular Disease”, SFB LIPTOX F3018, P27108, LipoLUNG (P 30968))
Marshallplan-Jubiläumsstiftung
Lustgarten Foundation (SU2C)
National Cancer Institute (P30 CA1405141, R01 CA168653, R35CA242379)
European Research Council (LipoCHEX (340896))
Harvard Catalyst (KL2 TR002542)
- License Information
-
More Information
Article History
Received: 11 May 2020
Accepted: 1 November 2020
First Online: 26 November 2020
Ethics approval and consent to participate
: The animal study was approved by the institutional ethics committee, and experiments were performed according to the guidelines of the Austrian Federal Ministry of Science and Research. Experiment licenses were granted under BMWF-66.007/0026-WF/V/3b/2015 and BMWF-66.007/0008-WF/V/3b/2016. In vivo, CB-839 experiments were approved by the MIT Committee on Animal Care (IACUC).
: Not applicable.
: The authors declare no competing interests.
